Chemotherapy-free radiotherapy combined with immunotherapy for locally advanced non-small cell lung cancer
10.3760/cma.j.cn113030-20240826-00325
- VernacularTitle:局部晚期非小细胞肺癌“豁免化疗”的放疗联合免疫治疗进展
- Author:
Meiqi WANG
1
;
Yongxing BAO
;
Yunsong LIU
;
Zhouguang HUI
Author Information
1. 国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院放疗科，北京 100021
- Publication Type:Journal Article
- Keywords:
Carcinoma, non-small cell lung;
Radiotherapy;
Immunotherapy
- From:
Chinese Journal of Radiation Oncology
2025;34(7):711-717
- CountryChina
- Language:Chinese
-
Abstract:
Consolidation with immunotherapy following concurrent chemoradiotherapy is current standard for treating unresectable locally advanced non-small cell lung cancer (LA-NSCLC). However, in clinical practice, many patients are ineligible for chemotherapy. Additionally, with the development of precision medicine, there is growing interest in chemotherapy-free regimen in order to enhance efficacy while reducing toxicity. In this article, current progress, challenges, and future directions of clinical research on the combination of chemotherapy-free radiotherapy and immunotherapy for LA-NSCLC were illustrated.
